Literature DB >> 25217960

Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation.

Neil Romberg1, Khatoun Al Moussawi2, Carol Nelson-Williams3,4, Amy L Stiegler5, Erin Loring3, Murim Choi3,4, John Overton3, Eric Meffre2,6, Mustafa K Khokha1,3, Anita J Huttner7, Brian West7, Nikolai A Podoltsev2, Titus J Boggon5, Barbara I Kazmierczak2,8, Richard P Lifton2,3,4.   

Abstract

Upon detection of pathogen-associated molecular patterns, innate immune receptors initiate inflammatory responses. These receptors include cytoplasmic NOD-like receptors (NLRs) whose stimulation recruits and proteolytically activates caspase-1 within the inflammasome, a multiprotein complex. Caspase-1 mediates the production of interleukin-1 family cytokines (IL1FCs), leading to fever and inflammatory cell death (pyroptosis). Mutations that constitutively activate these pathways underlie several autoinflammatory diseases with diverse clinical features. We describe a family with a previously unreported syndrome featuring neonatal-onset enterocolitis, periodic fever, and fatal or near-fatal episodes of autoinflammation. We show that the disease is caused by a de novo gain-of-function mutation in NLRC4 encoding a p.Val341Ala substitution in the HD1 domain of the protein that cosegregates with disease. Mutant NLRC4 causes constitutive IL1FC production and macrophage cell death. Infected macrophages from affected individuals are polarized toward pyroptosis and exhibit abnormal staining for inflammasome components. These findings identify and describe the cause of a life-threatening but treatable autoinflammatory disease that underscores the divergent roles of the NLRC4 inflammasome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25217960      PMCID: PMC4177367          DOI: 10.1038/ng.3066

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


Secretion of IL1FCs (IL-1 and IL-18) normally requires two signals. “Signal 1”, from membrane-spanning receptors (e.g. toll-like), induces expression of pro-IL1FCs[2]. “Signal 2”, from cytosolic detectors including NOD-like receptors (NLRs), leads to pro-caspase-1 autoproteolysis and activation[1]. Cleaved caspase-1 converts pro-IL-1 cytokines into their active forms[2,4]. One NLR, NLRC4, cooperates with NAIP to detect flagellin or components of the type three secretion system (TTSS), used by S. typhimurium and P. aeruginosa to infect host cells[5,6]. Upon ligand binding, NAIP and NLRC4 oligomerize and recruit the adaptor protein ASC (apoptosis associated speck-like protein containing a CARD)[7,8]. This macromolecular (>1 μm diameter) NLRC4 inflammasome induces autoproteolysis of pro-caspase-1 with subsequent IL1FC secretion and pyroptosis[1,7]. Mutant mice that cannot co-localize ASC and cleaved caspase-1 lose cytokine secretion yet retain pyroptosis.[6,9,10] The index patient (, III.3) presented at one week of life with secretory diarrhea and fever (38.8°C); no infectious cause was identified. Markers of systemic inflammation were elevated, including ferritin (4,840 ng/ml; nl 18-370 ng/ml) () and C-reactive protein (). Natural killer cells (NK cells) were reduced. Hypertriglyceridemia, hypofibrinoginemia, coagulopathy and pancytopenia developed, culminating in death on day 23 from diffuse alveolar hemorrhage. Autopsy revealed splenomegaly, numerous activated (CD163+) macrophages infiltrating the central nervous system ( and widespread bowel autolysis. Remaining intestinal tissue showed mixed inflammatory cells and villous blunting ( upper panel). Two days after the index patient's funeral, his 43-year-old father ( patient II.3) presented with fever (40.6 °C), acute respiratory distress syndrome, subarachnoid hemorrhage and hematochezia; disseminated intravascular coagulation and pancytopenia developed, with elevated ferritin (29,200 ng/ml), IL-18 (11,934 pg/ml; nl 69-503 pg/ml), C-reactive protein and soluble IL-2R (). Bone marrow biopsy showed erythro- and myelophagocytosis (). Ultrasonography revealed splenomegaly. NK-cell lymphopenia was prominent. As no infectious agent was isolated, high-dose intravenous immunoglobulin, dexamethasone and cyclosporine were instituted for immunosuppression. He gradually improved and was discharged after 9 weeks, remaining on cyclosporine; serum ferritin normalized but IL-18 remained markedly elevated (). He subsequently reported a lifelong history of periodic fevers (>40 °C) provoked by physical and emotional stressors. During infancy he had an extended hospitalization for fever, vomiting, non-bloody diarrhea and failure to thrive; no specific diagnosis was made. His gastrointestinal symptoms resolved by one year. In adulthood erythematous plaques and joint pains accompanied fevers; sero-negative psoriatic arthritis was diagnosed. The father's family history revealed healthy parents and two additional offspring, one without illness and a five-year-old half-brother (III.2) of the deceased infant (III.3) who also had periodic fevers (range 38.9 - 40 °C) beginning on day three of life after circumcision. A more severe febrile episode associated with vomiting, non-hemolytic anemia and acute renal failure occurred at 6-weeks of age (). Later his fevers were induced by over-exertion and accompanied by abdominal pain. A duodenal biopsy in the first year revealed villous blunting and intraepithelial lymphocytes (, lower panel). Inflammatory markers including ferritin (516-856 ng/ml), C-reactive protein, soluble IL-2R and plasma IL-18 (11,520 to 24,129 pg/ml) were persistently elevated (. NK cells, normal in number, were dysfunctional by chromium release assays (). Clinical signs of chronic inflammation included short stature (< 3rd percentile for height and weight) and recurrent myalgias. During the index case's acute illness, the possibility of a novel genetic syndrome was considered, leading to exome sequencing of the index case and his parents (see Methods). Clincial features suggesting hemophagocytic lymphohistiocytosis led to examination of genes implicated in this syndrome[11]; no rare variants were identified (). Upon the father's illness, 34 novel protein-altering variants (absent in dbSNP, 1000 genomes, NHLBI and Yale exome databases) shared by the index case and his father were identified, including six occurring at positions invariant among orthologs (). While none of these altered genes causing known inflammatory diseases, one was in NLRC4, which encodes a core inflammasome protein. This p.Val341Ala variant occurs within helical domain 1 (HD1), which provides a ‘lid’ to the ADP nucleotide-binding domain (NBD) in the crystal structure of inactive NLRC4 ( Ligand binding normally opens this structure, leading to exchange of ATP for ADP, promoting oligomerization and inflammasome assembly[12]. Gain-of-function mutations in the NBD of the related protein NLRP3 cause constitutive NLRP3 inflammasome assembly, resulting in production of IL-1β, fever and a spectrum of autoinflammatory disorders, the cryopyrinopathies[13-15]. These diseases are clinically distinct from the disease in our family as the cryopyrinopathies lack gastrointestinal pathology[16]. Evaluation of NLRC4 in the extended family demonstrated that it occurred de novo in the affected father, and co-segregated with the inflammatory disease (). None of the other five novel variants at conserved positions showed co-segregation with disease or de novo mutation. The finding of a de novo mutation in NLRC4, that co-segregates with a consistent clinical syndrome and biomarkers of inflammasome activation, provides strong evidence that NLRC4 causes this syndrome (syndrome of enterocolitis and autoinflammation associated with mutation in ; SCAN4). To evaluate the consequence of NLRC4V341A, we co-transfected wildtype or mutant human NLRC4 into HEK293 cells with human ASC and CASP1 and measured cleavage of procaspase-1. As anticipated, cleavage of pro-caspase-1 was ASC-dependent ()[6]. Compared to NLRC4, cells expressing NLRC4 showed 4-fold increased spontaneous production of caspase-1 p35 (P=0.004; ). Assembled inflammasomes form discrete foci in cells. We counted GFP-tagged ASC foci in cells expressing NLRC4WT or NLRC4V341A. These foci were more frequently present in mutant than wildtype cells (12.3% versus 7.6%; P<0.0001) (). Multiple ASC foci were not observed in any transfected HEK293 cells. We investigated constitutive NLRC4 inflammasome activation in macrophages derived from peripheral blood monocytes of SCAN4 patients (II.3 and III.2) and healthy related (n=1) and unrelated (n=4) controls. Without a “signal 2” (i.e., NLR ligand), control macrophages did not form ASC foci nor did they stain with biotin-YVAD-FMK (which binds activated caspase-1; ). In contrast, 3.3% of SCAN4 macrophages spontaneously formed ASC foci and 25.9% showed biotin-YVAD-FMK staining, similar to NLRC4- transfected HEK293 cells (). We cultured patient-derived or healthy donor macrophages for 18 hours with “signal 1” provocation (1 ng/ml LPS). As expected, without a “signal 2”, healthy control macrophages showed no detectable secretion of IL-1β (<1.4 pg/ml) and small amounts of IL-18 (22 pg/ml). In contrast, macrophages from both SCAN4 patients (II.3 and III.2) secreted markedly increased IL-1β (76 pg/ml) and IL-18 (212 pg/ml) (P<0.0001 vs. controls for both; ). We measured cell death-associated LDH release in the same 18-hour culture supernatants. SCAN4 macrophages released more LDH than healthy control macrophages (12.3% versus 4.7% P<0.0001) (). Addition of Z-YVAD-FMK, which inhibits the catalytic site of cleaved caspase-1, significantly reduced IL-1 family secretion, but did not reduce cell death (). Thus NLRC4V341A is gain-of-function, eliminating the requirement for “signal 2” for activation of caspase-1 and production of IL1FCs. NLRC4V341A also promotes pyroptosis independent of caspase-1 cytokine processing. We next infected LPS-primed healthy control or patient macrophages with either of two flagellated, TTSS-positive pathogens, S. typhimurium (strain SL1344) or P. aeruginosa (strain PAKΔSTY), thus providing both ‘signal 1’ and ‘signal 2’ provocation. As anticipated, LPS-primed healthy control macrophages secreted abundant IL1FCs and initiated pyroptosis upon infection (). Responses were reduced when infected with P. aeruginosa strain PAKΔpopD, which lacks a functional TTSS (). In contrast, SCAN4 macrophages secreted significantly less IL1FCs upon infection with pathogenic strains, yet showed more cell death than healthy control macrophages (). Infected macrophages form inflammasomes microscopically identifiable as ASC foci which co-localize with caspase-1. Consistent with published reports using murine macrophages[9,17] we found that 93% of S. typhimurium-infected and 97% of PAKΔSTY-infected healthy control macrophages formed 1-3 large diameter (>1 μm) ASC foci (, left panel, and b and , left panel, and b). Most S. typhimurium (71%) or PAKΔSTY (67%)-infected cells with 1-3 ASC foci showed caspase-1 proteolysis, indicated by diffuse cytoplasmic biotin-YVAD-CMK staining (, left panel, and c and , left panel, and c). Consistent with previous reports,[17,18] ASC foci in most S. typhimurium infected cells from healthy donors colocalized with aggregates of activated caspase-1 (. A small percentage of healthy donor cells (1.1% of S. typhimurium-infected control macrophages), had >6 ASC foci per cell; 93% of these stained with biotin-YVAD-FMK (, left panel, and c). In PAKΔSTY-infected cells, none had >6 ASC foci (, left panel, and c). In contrast, SCAN4 macrophages showed more frequent cells with >6 ASC foci (6.8% for S. typhimurium-infected and 5.6% for PAKΔSTY-infected macrophages, each P<0.0001 vs. controls). Rare macrophages had more than 20 ASC foci (, right panels, and b and , right panels, and b). Caspase-1 activation was generally limited in infected SCAN4 macrophages. Even in macrophages displaying >6 foci, only 50% infected with S. typhimurium and 44% infected with PAKΔSTY displayed diffuse cytoplasmic biotin-YVADCMK staining (P<0.0001 and P=0.0012 vs wildtype, respectively) (, right panels, and c and , right panels, and c). In contrast to wildtype cells, ASC foci in S. typhimurium infected SCAN4 cells did not colocalize with aggregates of activated caspase-1 (). Lastly, ASC foci in biotin-YVAD-CMK negative macrophages were significantly smaller than in biotin-YVAD-CMK positive cells in both healthy controls and SCAN4 patients ( and ). These findings describe a previously unreported Mendelian autoinflammatory syndrome featuring periodic fever, neonatal-onset enterocolitis and high levels of IL1FCs, and demonstrate its causation by a gain-of-function mutation in NLRC4. Like NLRP3 cryopyrinopathies[14], SCAN4 is associated with constitutive activation of caspase-1 and production of IL1FCs. In the inhibited, ADP-bound state, Val341 of NLRC4 makes van der Waals contacts with side chains of an adjacent helix in the HD1 domain, comprising the ‘lid’ on the nucleotide-binding site. The decreased hydrophobicity of the Ala341 mutation may reduce this interaction, allowing more movement of helix α12 and promoting ATP for ADP exchange, either by favoring the open conformation of NLRC4, or by disrupting the stabilizing interaction of His443 with the beta-phosphate of ADP (). Either possibility would promote ligand-independent activation of NLRC4. It is compelling that Canna et al. have identified an independent de novo mutation in NLRC4, p.Thr337Ser[19]. The identification of two de novo mutations in close proximity in the same gene that segregate with a novel clinical phenotype provides strong support for a causal relationship of the mutations to disease pathogenesis. SCAN4 is distinctive from NLRP3 cryopyrinopathies in its association with neonatal-onset enterocolitis. This may relate to NLRC4 being highly expressed in intestinal macrophages while NLRP3 is not[20]. It is interesting that the marked enterocolitis of each surviving SCAN4 patient resolved by one year of age. We speculate that this chronic inflammatory state may be exacerbated in the infant gut by constant “signal 1” provocation from newly acquired symbionts. As host-microbe interactions mature, a less pro-inflammatory microflora may account for reduced gut inflammation[21]. IL-1β - targeted drugs are approved for treatment of NLRP3 cryopyrinopathies[22-24]. We expect IL-1β blockade will be similarly effective in SCAN4 patients. Although both surviving members in our family have presently declined interictal therapy, the complementary report by Canna et al provides evidence for efficacy of IL-1 receptor blockade[19]. SCAN4 macrophages show high IL1FC secretion and increased cell death with “signal 1” despite the absence of “signal 2”; addition of “signal 2” frequently produces multiple ASC foci with increased cell death, despite blunted IL1FC secretion. One possible explanation is that mutant NLRC4 promotes traditional inflammasome assembly in the absence of “signal 2” provocation but intracellular ligand binding promotes formation of ASC foci that lack activated caspase-1, resulting in smaller structures with impaired ability to produce cytokines. This proposal is supported by mice with mutated inflammasome components[6,9,10] which demonstrate defective cytokine processing yet intact pyroptosis . Modulating the balance between cytokine production and pyroptosis may determine the distinct states of subclinical autoinflammation, periodic fever, and fatal or near-fatal autoinflammation seen in SCAN4 patients.

ONLINE METHODS

Research Subjects

The study protocol was approved by the Yale Human Research Protection Program. Informed consent was provided by all participants or their legal guardians. Clinical data was abstracted from medical records. Tissues from biopsy and autopsy specimens were labeled using standard hematoxylin and eosin staining protocols or by immunohistochemical staining with an anti-CD163 antibody (Abcam).

Genetic analysis

DNA was prepared from venous blood samples of the index case and kindred members. Exome sequencing of the index case and his parents was performed by capture on the NimbleGen 2.1 Exome reagent followed by 74 base paired end sequencing on the Illumina platform to high coverage (each targeted base was read by a mean of more than u80 independent reads in each subject) as previously described26. Sequences were aligned to NCBI Build 36 of the human genome and SNV and indel calls were assigned quality scores (QS) using SAMtools and annotated for novelty (using Yale, 1000 genomes, and NHLBI exome databases), for impact on encoded proteins, and for conservation of variant position as previously described26. Variants were sought in genes implicated in hemophagocytic lymphohistiocytosis; none were identified (). Thirty-four protein-altering variants that were absent in dbSNP, 1000 genomes, NHLBI and Yale exome databases that were shared by the index case and affected father were identified () and evaluated. Only one was in a gene known to play a role in activation of the innate immune system (NLRC4). Variants in NLRC4 and the other 5 genes in which novel variants that occurred at completely conserved positions (ALK, DCC, FBXO4, KIF13B, and SLC7A6OS) were confirmed by PCR amplification followed by Sanger sequencing and transmission through the complete pedigree was evaluated. The NLRC4 variant proved to be de novo in the affected father and perfectly cosegregated with the autoinflammatory syndrome in the pedigree, while the others were all transmitted from an unaffected grandparent of the index case and did not co-segregate with disease. The NLRC4 p.Val341Ala mutation has been deposited into the National Center for Biotechnology Information's ClinVar database (ClinVar accession #, SCV000172282)

Functional analysis of V341A altered NLRC4

NLRC4 activity was analyzed in HEK293-cells. Wild-type human NLRC4 was cloned into pMycB (Santa Cruz Biotech) and verified by Sanger sequencing. The c.1022 T->C mutation was introduced by site-directed mutagenesis (Stragene QuikChange) and verified by Sanger sequencing. Mutated and wildtype myc-NLRC4 were transiently transfected into HEK293 cells along with N-terminal FLAG-human pro-caspase-1 and GFP-tagged human ASC using Lipofectamine2000 (Invitrogen). NLRC4 activity was visually measured 30h after transfection by spontaneous formation of GFP-ASC foci (as visualized in live cells by epifluorescent microscopy). Manual enumeration of ASC foci+ was performed over 20 representative fields at 20x magnification. Pro-caspase-1 p45 autoproteolysis was measured directly by western blotting for p35 (anti-FLAG M2 (F1804), 1:1000; Sigma) and p10 fragments (anti-caspase-1 p10 (sc-514), 1:200; Santa Cruz Biotech), using anti-mouse IgG-HRP or anti-rabbit IgG-HRP (Biorad) and enhanced chemiluminescence. The presence of NLRC4 and actin in lysates was confirmed by blotting with anti- c-Myc antibodies (9E10, 1:1000; Enzo Life Sciences) or anti-rabbit pan-actin polyclonal antibody (#4970, 1:5000; Cell Signaling Technology), respectively.

Functional studies of monocyte derived macrophages

CD14+ monocytes were purified from peripheral blood mononuclear cells of SCAN4 patients and healthy donor controls using anti-human CD14 magnetic beads (Miltenyi). Cells from the two living SCAN4 patients were used for all functional studies whereas the number and relatedness of healthy donors used varied from experiment to experiment and was based upon same-day availability. Monocytes were differentiated to macrophages in RPMI containing 10% FBS and M-CSF (10ng/ml) over 7 days[27]. 2 × 105 macrophages were cultured for 18 hours in culture media containing LPS (1ng/ml) with or without Z-YVAD-FMK (Enzo Life Sciences) at 0.1-0.5μM concentrations. Culture supernatants were collected and cells washed and re-cultured with LPS free media before infection with P. aeruginosa or S. typhimurium. PAKΔSTY and SL1344 are flagellated strains that are type 3 secretion system (T3SS)-positive. PAKΔpopD is a Fla+ strain that does not express a functional T3SS. Construction and characterization of bacterial strains has been previously described[6,28]. Infected macrophage culture supernatants were collected after one hour. Secreted IL-1β and IL-18 were measured by ELISA (Millipore and MBL, respectively) in both the 18-hour and one-hour culture supernatants. Cell-free LDH was measured according to manufacturer's protocol (Takara). LDH release in supernatants was normalized to LDH released from macrophages lysed with Triton X-100 (0.1%).

Immunofluoresence microscopy of infected macrophages

2×105 macrophages, differentiated as above, were plated on glass coverslips. Cells were incubated with 2 μM biotin-YVAD-CMK for 30 minutes prior to infection with P. aeruginosa PAKΔSTY or ΔpopD or S. typhimurium SL1344 at a multiplicity of infection of 20 bacteria/cell for 1 hour. Cell were fixed with paraformaldehyde (4%), blocked with 1% fish scale gelatin (Sigma) in PBS + 0.1% TX-100, and stained with rabbit anti-ASC (AL177; AdipoGen) and 4’,6-Diamidino-2-phenylindole (Sigma). A streptavidin-Alexa Fluor 488 conjugate (Invitrogen) and anti-rabbit Alexa Fluor 594 antibody (Life Technologies) were used for secondary stainings. Macrophages were visually inspected for immunofluorescence using an Axiovert 200M microscope. Manual enumeration of ASC+ and YVAD+ macrophages was performed over 20 representative fields at 20x magnification. DAPI staining of bacterial DNA was used to confirm macrophage infection. High detail magnification for phased images at 60X and 100X was performed on a Nikon Eclipse TE2000-S microscope.
  28 in total

1.  De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.

Authors:  Ivona Aksentijevich; Miroslawa Nowak; Mustapha Mallah; Jae Jin Chae; Wendy T Watford; Sigrun R Hofmann; Leonard Stein; Ricardo Russo; Donald Goldsmith; Peter Dent; Helene F Rosenberg; Frances Austin; Elaine F Remmers; James E Balow; Sergio Rosenzweig; Hirsh Komarow; Nitza G Shoham; Geryl Wood; Janet Jones; Nadira Mangra; Hector Carrero; Barbara S Adams; Terry L Moore; Kenneth Schikler; Hal Hoffman; Daniel J Lovell; Robert Lipnick; Karyl Barron; John J O'Shea; Daniel L Kastner; Raphaela Goldbach-Mansky
Journal:  Arthritis Rheum       Date:  2002-12

2.  Isolation and differentiation of monocytes-macrophages from human blood.

Authors:  Dipti Vijayan
Journal:  Methods Mol Biol       Date:  2012

Review 3.  Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation.

Authors:  Sanjeev Mariathasan; Denise M Monack
Journal:  Nat Rev Immunol       Date:  2007-01       Impact factor: 53.106

Review 4.  How I treat hemophagocytic lymphohistiocytosis.

Authors:  Michael B Jordan; Carl E Allen; Sheila Weitzman; Alexandra H Filipovich; Kenneth L McClain
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

5.  Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.

Authors:  Hal M Hoffman; Martin L Throne; N J Amar; Mohamed Sebai; Alan J Kivitz; Arthur Kavanaugh; Steven P Weinstein; Pavel Belomestnov; George D Yancopoulos; Neil Stahl; Scott J Mellis
Journal:  Arthritis Rheum       Date:  2008-08

6.  Use of canakinumab in the cryopyrin-associated periodic syndrome.

Authors:  Helen J Lachmann; Isabelle Kone-Paut; Jasmin B Kuemmerle-Deschner; Kieron S Leslie; Eric Hachulla; Pierre Quartier; Xavier Gitton; Albert Widmer; Neha Patel; Philip N Hawkins
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

7.  Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra.

Authors:  Philip N Hawkins; Helen J Lachmann; Ebun Aganna; Michael F McDermott
Journal:  Arthritis Rheum       Date:  2004-02

8.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.

Authors:  Laetitia Agostini; Fabio Martinon; Kimberly Burns; Michael F McDermott; Philip N Hawkins; Jürg Tschopp
Journal:  Immunity       Date:  2004-03       Impact factor: 31.745

9.  Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome.

Authors:  Fayyaz S Sutterwala; Lilia A Mijares; Li Li; Yasunori Ogura; Barbara I Kazmierczak; Richard A Flavell
Journal:  J Exp Med       Date:  2007-12-10       Impact factor: 14.307

10.  An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.

Authors:  Scott W Canna; Adriana A de Jesus; Sushanth Gouni; Stephen R Brooks; Bernadette Marrero; Yin Liu; Michael A DiMattia; Kristien J M Zaal; Gina A Montealegre Sanchez; Hanna Kim; Dawn Chapelle; Nicole Plass; Yan Huang; Alejandro V Villarino; Angelique Biancotto; Thomas A Fleisher; Joseph A Duncan; John J O'Shea; Susanne Benseler; Alexei Grom; Zuoming Deng; Ronald M Laxer; Raphaela Goldbach-Mansky
Journal:  Nat Genet       Date:  2014-09-14       Impact factor: 38.330

View more
  166 in total

1.  Inflammasome assembly: The wheels are turning.

Authors:  Petr Broz
Journal:  Cell Res       Date:  2015-11-24       Impact factor: 25.617

Review 2.  Genetically defined autoinflammatory diseases.

Authors:  A A de Jesus; R Goldbach-Mansky
Journal:  Oral Dis       Date:  2016-04-14       Impact factor: 3.511

Review 3.  Regulation of inflammasome activation.

Authors:  Si Ming Man; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

Review 4.  Pyroptotic cell death defends against intracellular pathogens.

Authors:  Ine Jorgensen; Edward A Miao
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

5.  Editorial: 21st Century Storm Chasers: Defining Macrophage Activation Syndrome.

Authors:  Scott W Canna; Peter A Nigrovic
Journal:  Arthritis Rheumatol       Date:  2016-03       Impact factor: 10.995

6.  Functional and genetic testing in adults with HLH reveals an inflammatory profile rather than a cytotoxicity defect.

Authors:  Julien Carvelli; Christelle Piperoglou; Catherine Farnarier; Frédéric Vely; Karin Mazodier; Sandra Audonnet; Patrick Nitschke; Christine Bole-Feysot; Mohamed Boucekine; Audrey Cambon; Mohamed Hamidou; Jean-Robert Harle; Geneviève de Saint Basile; Gilles Kaplanski
Journal:  Blood       Date:  2020-07-30       Impact factor: 22.113

Review 7.  Inflammasomes and intestinal inflammation.

Authors:  N Zmora; M Levy; M Pevsner-Fishcer; E Elinav
Journal:  Mucosal Immunol       Date:  2017-04-12       Impact factor: 7.313

Review 8.  The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.

Authors:  Kalpana Manthiram; Qing Zhou; Ivona Aksentijevich; Daniel L Kastner
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

Review 9.  The genetics of macrophage activation syndrome.

Authors:  Grant S Schulert; Randy Q Cron
Journal:  Genes Immun       Date:  2020-04-15       Impact factor: 2.676

Review 10.  Inflammatory osteolysis: a conspiracy against bone.

Authors:  Gabriel Mbalaviele; Deborah V Novack; Georg Schett; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.